Provided by Tiger Trade Technology Pte. Ltd.

BioRestorative Therapies, Inc.

0.2521
-0.0259-9.32%
Volume:429.83K
Turnover:110.77K
Market Cap:6.42M
PE:-0.16
High:0.2603
Open:0.2580
Low:0.2500
Close:0.2780
52wk High:2.05
52wk Low:0.1900
Shares:25.48M
Float Shares:24.18M
Volume Ratio:3.64
T/O Rate:1.78%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5837
EPS(LYR):-1.5837
ROE:-320.47%
ROA:-119.56%
PB:18.74
PE(LYR):-0.16

Loading ...

BioRestorative Therapies Inc - Offering Priced at $0.35 per Share With Warrants

THOMSON REUTERS
·
Feb 12

Biorestorative Announces Positive Outcome From Type B Meeting With FDA

Reuters
·
Feb 11

BioRestorative Therapies Inc: Currently Anticipates That Phase 3 Trial Ind Submission Will Be Made in Second Half of 2026

THOMSON REUTERS
·
Feb 11

BioRestorative Announces Positive Outcome from Type B Meeting with FDA

GlobeNewswire
·
Feb 11

BioRestorative completes patient enrollment in Phase 2 trial of BTRX-100

TIPRANKS
·
Feb 10

BioRestorative Therapies schließt Patientenrekrutierung für Phase-2-Studie zu BRTX-100 bei chronischer lumbaler Bandscheibenerkrankung ab

Reuters
·
Feb 10

BioRestorative Completes Patient Enrollment in Landmark Phase 2 Trial of BRTX-100 for Chronic Lumbar Disc Disease

GlobeNewswire
·
Feb 10

BioRestorative Therapies Inc. unveils regenerative medicine pipeline and commercial plans in new investor presentation

Reuters
·
Nov 22, 2025

BioRestorative Therapies files to sell 508,592 shares of common stock for holder

TIPRANKS
·
Nov 19, 2025

BioRestorative Therapies Inc - Type B Meeting Scheduled for Mid-December

THOMSON REUTERS
·
Nov 17, 2025

BioRestorative Granted Type B Meeting with FDA to Discuss Accelerated BLA Approval Pathway for BRTX-100 in Chronic Lumbar Disc Disease

GlobeNewswire
·
Nov 17, 2025

BioRestorative Therapies Q3 EPS $(0.33) Beats $(0.36) Estimate, Sales $11.800K Miss $460.000K Estimate

Benzinga
·
Nov 13, 2025

BioRestorative Therapies Q3 Net Income USD -3 Million

THOMSON REUTERS
·
Nov 13, 2025

BioRestorative Therapies Reports Third Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire
·
Nov 13, 2025

BioRestorative Therapies Inc expected to post a loss of 36 cents a share - Earnings Preview

Reuters
·
Nov 07, 2025

BioRestorative Therapies Says Granted Japanese Patent Allowance for Stem Cell Technology; Shares Up Pre-Bell

MT Newswires Live
·
Oct 27, 2025

BioRestorative Therapies Inc - Protected in Developing Alternatives to Glp-1 Drugs

THOMSON REUTERS
·
Oct 27, 2025

BioRestorative Awarded Notice of Allowance for Japanese Patent – Expands Protection for Potential Cell-Based Alternative to Multi-Billion Dollar GLP-1 Drug Market

GlobeNewswire
·
Oct 27, 2025

BioRestorative Therapies names Crystal Romano head, global commercial operations

TIPRANKS
·
Oct 22, 2025

BioRestorative Strengthens Commercial Leadership With Appointment of Crystal Romano as Head of Global Commercial Operations to Accelerate Growth of Cell-Based Product Portfolio

THOMSON REUTERS
·
Oct 22, 2025